CHAPTER 173

HB 1453 - FINAL VERSION

2016 SESSION

16-2469

01/04

HOUSE BILL 1453

AN ACT relative to qualifying medical conditions for purposes of therapeutic cannabis.

SPONSORS: Rep. Luneau, Merr. 10; Rep. Myler, Merr. 10; Rep. Wallner, Merr. 10; Sen. Feltes, Dist 15

COMMITTEE: Health, Human Services and Elderly Affairs

-----------------------------------------------------------------

ANALYSIS

This bill adds ulcerative colitis to the list of qualifying medical conditions for purposes of therapeutic cannabis.

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Explanation: Matter added to current law appears in bold italics.

Matter removed from current law appears [in brackets and struckthrough.]

Matter which is either (a) all new or (b) repealed and reenacted appears in regular type.

16-2469

01/04

STATE OF NEW HAMPSHIRE

In the Year of Our Lord Two Thousand Sixteen

AN ACT relative to qualifying medical conditions for purposes of therapeutic cannabis.

Be it Enacted by the Senate and House of Representatives in General Court convened:

173:1  Use of Cannabis for Therapeutic Purposes; Definition.  Amend RSA 126-X:1, IX(a)(1) to read as follows:

(1)  Cancer, glaucoma, positive status for human immunodeficiency virus, acquired immune deficiency syndrome, hepatitis C currently receiving antiviral treatment, amyotrophic lateral sclerosis, muscular dystrophy, Crohn's disease, multiple sclerosis, chronic pancreatitis, spinal cord injury or disease, traumatic brain injury, epilepsy, lupus, Parkinson's disease, Alzheimer's disease, ulcerative colitis, or one or more injuries that significantly interferes with daily activities as documented by the patient's provider; and

173:2  Effective Date.  This act shall take effect 60 days after its passage.

Approved: June 3, 2016

Effective Date: August 2, 2016